Brian Dickson
Director/Miembro de la Junta en American Society of Hypertension .
Perfil
Brian Dickson is currently the Director at the American Society of Hypertension and a Member at the Faculty of Pharmaceutical Medicine.
He previously worked as the Chief Executive Officer & Director at BioMarck Pharmaceuticals Ltd.
and as the Chairman at Peckforton Pharmaceuticals Ltd.
He also held Principal positions at Parke-Davis & Co. Ltd., G.D.
Searle & Co., Inc., and Smithkline & French Laboratories US, Inc. Additionally, he served as the Chief Medical Officer at Covalent Group, Inc., Inveresk Research Group, Inc., Critical Therapeutics, Inc., and Cornerstone BioPharma, Inc. He was also a Subcommittee Member-Nutrition & Anemia at the World Health Organization.
Dr. Dickson holds a doctorate degree from the University of Adelaide.
Cargos activos de Brian Dickson
Empresas | Cargo | Inicio |
---|---|---|
Faculty of Pharmaceutical Medicine | Corporate Officer/Principal | - |
American Society of Hypertension | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Brian Dickson.
Empresas | Cargo | Fin |
---|---|---|
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Director Ejecutivo | 01/05/2020 |
CORNERSTONE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 16/10/2009 |
Cornerstone BioPharma, Inc.
Cornerstone BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone BioPharma, Inc. develops and commercializes biopharmaceutical products for respiratory disorders. Its products include AlleRx, Balacet, Deconsal, and Spectracef. The company was founded in March 2004 by Craig A. Collard, Chenyqua Baldwin, and Steven Lutz and is headquartered in Cary, NC | Director Técnico/Científico/I+D | 04/11/2008 |
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Corporate Officer/Principal | 01/12/2004 |
Covalent Group, Inc. | Director Técnico/Científico/I+D | 01/01/2003 |
Formación de Brian Dickson.
University of Adelaide | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 14 |
---|---|
Cornerstone BioPharma, Inc.
Cornerstone BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone BioPharma, Inc. develops and commercializes biopharmaceutical products for respiratory disorders. Its products include AlleRx, Balacet, Deconsal, and Spectracef. The company was founded in March 2004 by Craig A. Collard, Chenyqua Baldwin, and Steven Lutz and is headquartered in Cary, NC | Health Technology |
Smithkline & French Laboratories US, Inc. | |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Health Technology |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Health Technology |
Covalent Group, Inc. | Commercial Services |
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Commercial Services |
World Health Organization
World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Government |
Critical Therapeutics, Inc. | Health Technology |
Cornerstone Therapeutics, Inc.
Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
Peckforton Pharmaceuticals Ltd.
Peckforton Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Peckforton Pharmaceuticals Ltd. engages in the manufacture, distribution, and sale of pharmaceutical products. It is focused into two divisions, Branded and Hospital. Each division has distinct and separate requirements to support both the patient and the healthcare professional. The company was founded on April 11, 1995 and is headquartered in Crewe, the United Kingdom. | Health Technology |
Faculty of Pharmaceutical Medicine | |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Health Technology |
American Society of Hypertension |
- Bolsa de valores
- Insiders
- Brian Dickson